Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis.
about
Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine.Systemic Chemokine Levels with "Gut-Specific" Vedolizumab in Patients with Inflammatory Bowel Disease-A Pilot StudySerum interleukin-6 level is associated with response to infliximab in ulcerative colitis.
P2860
Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Changes in cytokine profile ma ...... ients with ulcerative colitis.
@en
Changes in cytokine profile ma ...... ients with ulcerative colitis.
@nl
type
label
Changes in cytokine profile ma ...... ients with ulcerative colitis.
@en
Changes in cytokine profile ma ...... ients with ulcerative colitis.
@nl
prefLabel
Changes in cytokine profile ma ...... ients with ulcerative colitis.
@en
Changes in cytokine profile ma ...... ients with ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Changes in cytokine profile ma ...... ients with ulcerative colitis.
@en
P2093
Shoko Sato
Shotaro Nakamura
Takayuki Matsumoto
Toshimi Chiba
P2860
P304
P356
10.1111/JGH.13008
P577
2015-05-13T00:00:00Z